CyclinD1 and p57(kip2) as biomarkers in differentiation, metastasis and prognosis of gastric cardia adenocarcinoma.
CyclinD1 and p57(kip2) as biomarkers in differentiation, metastasis and prognosis of gastric cardia adenocarcinoma.
复制标题
DOI:
10.18632/oncotarget.18008
复制
发表时间:
2017-09-26
期刊:
影响因子:
--
通讯作者:
Feng XS
中科院分区:
文献类型:
--
作者:
Ru Y;Chen XJ;Zhao ZW;Zhang PF;Feng SH;Gao Q;Gao SG;Feng XS
This study aims to investigate the expression and significance of p57kip2 and cyclinD1 in gastric cardia adenocarcinoma (GCA). p57kip2 is a negative regulator in the cell cycle. On the contrary, cyclinD1 is a positive regulator of cell cycle progression. Thirty-two cases of GCA tissues and adjacent non-cancerous tissues were collected for this study. Immunohistochemistry and fluorescence qualitative PCR was used to determine the level of p57kip2 and cyclinD1 in GCA and its adjacent non-cancerous tissues. Furthermore, the correlation between the mRNA/protein and GCA clinical pathologic parameters were analyzed, and the relationship of p57kip2 and cyclinD1 in GCA were also evaluated. The expression of p57kip2 significantly lower in GCA (P = 0.036), and there was a significant correlation in the different degrees of differentiation (P < 0.05). Furthermore, median survival time was 41 months for patients with high mRNA expression of p57kip2. This was longer compared to patients with low mRNA expression of P57kip2 (37 months, X2 = 4.788, P = 0.029).The expression of cyclinD1 was significantly higher in GCA(P = 0.002), and was significant correlated to clinical stage(P<0.05). Median survival time was 34 months in patients with high mRNA expression of cyclinD1, which was shorter than in patients with low expression of cyclinD1 mRNA (41 months, X2 = 4.071, P = 0.044). The protein expression of p57kip2 was not correlated to the protein expression of cyclinD1 (P = 0.55). The expression of p57kip2 and cyclinD1 are likely to suppress or promote the tumorigenesis and progression of GCA.
登录
查看更多内容
影响因子:
6.7
作者:
Bazot Q;Paschos K;Skalska L;Kalchschmidt JS;Parker GA;Allday MJ
通讯作者:
Allday MJ
DOI:
10.1093/ijnp/pyu121
发表时间:
2015-01-07
期刊:
The international journal of neuropsychopharmacology
影响因子:
--
作者:
Yang C;Shirayama Y;Zhang JC;Ren Q;Hashimoto K
通讯作者:
Hashimoto K
影响因子:
3.8
作者:
Barnes, DM;Gillett, CE
通讯作者:
Gillett, CE
影响因子:
8
作者:
Kuang, S-Q;Ling, X.;Garcia-Manero, G.
通讯作者:
Garcia-Manero, G.
影响因子:
1.3
作者:
Wang, B;Gao, ZQ;Yan, X
通讯作者:
Yan, X